Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Sequans Communications S.A. (SQNS): A Hot Penny Stock On The Move

We recently compiled a list of the 10 Hot Penny Stocks On the Move. In this article, we are going to take a look at where Sequans Communications S.A. (NASDAQ:SQNS) stands against the other hot penny stocks.

Interest Rate Cuts and The Stock Market

The economy of the United States has stabilized, the risks of a recession have been delayed, and inflation continues to cool down. On August 30, Reuters reported that the Federal Reserve received a fresh confirmation regarding inflation continuing to ease. The personal consumption expenditure price index rose 2.5% year-over-year in July and inflation has stayed within the 2% goal set by the Fed. Fed Chairman has indicated that the “time has come to cut rates”.

Moreover, in another report by Reuters on the same day there were reports of the US dollar gaining as another key inflation measure fell in line with the forecasts. The Fed is expected to cut rates by 25 basis points this month. Moving forward markets have forecasted 100 bps of cuts by the end of 2024.

The stock market is already riding the tide of expected interest rate cuts. On August 20, CNBC reported that the stock market was climbing yet again, putting the S&P 500 and NASDAQ on track for their eighth positive session in a row, marking their longest winning streak this year.

Nick Colas, DataTrek Research co-founder in a CNBC interview indicated a few more positive points for even more upside for the stock market. He expressed that he feels positive about the market and the slight shuffle that caused some volatility a few weeks ago is now over. He sees the market getting back to July levels.

Colas also pointed out that the small caps and cyclicals lead the market. We have covered Chris Retzler, Needham’s small-cap growth portfolio manager’s bull case for small caps in 10 Best Penny Stocks To Buy According to the Media. Here’s an excerpt from the piece:

“On July 17, Chris Retzler, Needham’s small-cap growth portfolio manager, appeared on CNBC where he expressed optimism for the small-cap companies and suggested that we are in a cycle that will be good for many small-cap companies. The Russell 2000 index jumped 3.5% higher on July 16, hitting the highest levels since January 2022, and was up more than 10% in the previous week. This was one of the biggest rallies investors have seen in the past 4 years.

Retzler believes that small-cap stocks have been waiting for a drop in inflation and interest rate cuts. With inflation easing, interest rates are expected to go down as well. He also sees the market broadening, with small companies that have underperformed benefiting from a drop in inflation.”

Similar to Retzler, Colas is also vouching for small caps to continue outperforming the market. He believes that the market has high expectations from the Fed and the current upside is a result of the news. Moreover, he also mentioned that the stock market tends to react both before and after the cuts have been made and believes that the same pattern of growth will follow if not more after the rate cut.

Our Methodology

To compile the list of 10 hot penny stocks on the move we used the Finviz stock screener. We set the price filter to under $5, current and average stock volume to over 750,000 and the performance filter to positive 30% during the last month. Using these filters we were able to accumulate a list of hot penny stocks on the move. Next we ranked these stocks based on their one month performance, as of August 30 2024. We have also added number of hedge funds that held the stock in Q2 2024.

Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A macro view of a 5G/4G chips and modules, displaying the cutting edge technology of the company.

Sequans Communications S.A. (NASDAQ:SQNS)

Share Price as of August 30: $0.96

Current Volume as of August 30: 2 million 

Number of Hedge Fund Holders: 8

1-Month Performance as of August 30: 92.28%

Sequans Communications S.A. (NASDAQ:SQNS) designs, manufactures, and supplies cellular semiconductor solutions primarily for the Internet of Things markets. It provides 4G and 5G chips and modules for non-smartphone devices including RF Transceivers, System-on-Chip Solutions, and LTE Modules.

The company’s semiconductor solutions have applications in smart mobility, logistics, smart cities, E-health, and more. It is based in Paris, France.

Sequans Communications S.A. (NASDAQ:SQNS) has gained significant investor attention since its latest earnings quarter, FQ2 2024 release. It has jumped up 92.28% during the past 30 days. A significant reason behind investors’ interest stems from Qualcomm Technologies acquiring Sequans’ 4G IoT technologies.

The company gets to maintain full ownership of the 5G intellectual properties and also retains the right to sell and enhance its existing 4G product portfolio. Management believes the transaction will enable the company to advance its Monarch, Calliope, and Cassiopeia 4G lines along with significant development to its 5G portfolio.

Moreover, it will also add significantly to the company’s balance sheet, providing it significant room for future growth. The quarter itself was encouraging as well. Sequans Communications S.A. (NASDAQ:SQNS) improved its revenue by 5.4% year-over-year, with License and services revenue accounting for 75% growth.

In addition, the gross profits of the company also grew from $7.5 million a year ago to $8.1 million, with operating loss decreasing significantly by around 31% year-over-year.

Moving forward management anticipates modest growth in the third quarter and much stronger growth in FQ4, due to the anticipated increase in products moving into mass production over the coming quarters.

The stock was held by 8 hedge funds in the second quarter of 2024, with total stakes worth $7.14 million. Lynrock Lake is the top shareholder with a position worth $4.36 million.

Overall SQNS ranks 3rd on our list of the hottest penny stocks on the move. While we acknowledge the potential of SQNS as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for a promising AI stock that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…